Health Care Distributors

ZeroStack

ZeroStack released FY2026 Q1 earnings on May 4, 2026 (EST), actual revenue USD 7.274 M (forecast USD 13.14 M), actual EPS USD -3.6814 (forecast USD -1.18)

ZeroStack released FY2025 Q4 earnings on February 27 (EST), actual revenue USD 9.353 M (forecast USD 9.328 M), actual EPS USD -11.9265 (forecast USD -0.39)

ZeroStack released FY2025 Annual Earnings on February 27 (EST), actual revenue USD 35.68 M (forecast USD 45.66 M), actual EPS USD -43.4914 (forecast USD -3.66)

ZeroStack released FY2025 Q2 earnings on November 5 (EST), actual revenue USD 0 (forecast USD 11.77 M), actual EPS USD 0 (forecast USD -2.34)

ZeroStack released FY2025 Semi-Annual earnings on November 5, 2025 (EST), with actual revenue of USD 16.58 M and actual EPS of USD -5.9754

ZeroStack released FY2025 Q3 earnings on November 5 (EST), actual revenue USD 9.748 M (forecast USD 12.52 M), actual EPS USD -9.0495 (forecast USD -2.13)

ZeroStack released FY2025 9 Months Earnings on November 5 (EST), actual revenue USD 16.61 M, actual EPS USD -10.5902

ZeroStack released FY2024 9 Months Earnings on November 5 Pre-Market EST, actual revenue USD 25.27 M, actual EPS USD -25.9299

ZeroStack released FY2024 Semi-Annual Earnings on November 5 Pre-Market (EST), actual revenue USD 20.98 M, actual EPS USD -22.2114

ZeroStack released FY2024 Q3 earnings on November 5 Pre-Market EST, actual revenue USD 7.238 M (forecast USD 16.75 M), actual EPS USD -11.1099

ZeroStack released FY2024 Q2 earnings on November 5 Pre-Market (EST), actual revenue USD 0 (forecast USD 20.74M), actual EPS USD 0

ZeroStack released FY2025 Q1 earnings on May 13 (EST), actual revenue USD 6.866 M (forecast USD 14.79 M), actual EPS USD -1.5406 (forecast USD -6.24)

ZeroStack released FY2024 Q1 earnings during market hours on May 13 (EST), actual revenue USD 18.03 M (forecast USD 19.04 M), actual EPS USD -14.8199

ZeroStack released FY2023 Q4 earnings on March 24 (EST), actual revenue USD 17.98 M (forecast USD 16.52 M), actual EPS USD -43.2496

ZeroStack released FY2024 Q4 earnings on March 24 (EST), actual revenue USD 7.646 M (forecast USD 13.51 M), actual EPS USD -15.8397

ZeroStack released FY2024 Annual Earnings on March 24 (EST), Actual Revenue: USD 35.87 M (Forecast: USD 59.69 M), Actual EPS: USD -50.022

ZeroStack released FY2023 Annual Earnings on March 24 (EST), actual revenue USD 76.07 M (forecast USD 90 M), actual EPS USD -302.3937

Netcapital

Agape ATP

Tradr 2X Long QBTS Daily ETF

Akanda

Defiance Daily Target 2X Long RGTI ETF

PicoCELA

Tradr 2X Long RGTI Daily ETF

Co-Diagnostics

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NewGenIvf

ZSTK

ZeroStack Corp. reported Q1 2026 revenue of $7.27M, a 5.9% increase from $6.87M in Q1 2025. The company faced a net loss of $(36.66) M and a diluted EPS of $(3.68). Revenue growth was attributed to Phatebo pharmaceutical sales and $2.8M from staking rewards. ZeroStack is focusing on digital-asset staking as a core revenue stream and has taken steps to regain Nasdaq compliance by appointing independent directors and rebuilding committees.

TradingView

Nasdaq

ZeroStack Corp. 1Q 2026: Revenue $7.27M, EPS $(3.68) — 10-Q Summary

Earnings Watch

ZeroStack | 10-Q: FY2026 Q1 Revenue: USD 7.274 M

WALD

In Wednesday's after-market session, several consumer staples stocks experienced notable movements. Medifast (NYSE:MED) saw a significant increase of 9.9% to $12.0, while ZeroStack (NASDAQ:ZSTK) rose 7.14% to $6.0. Other gainers included Waldencast (NASDAQ:WALD) up 5.29% to $0.8, and Sprouts Farmers Market (NASDAQ:SFM) up 3.75% to $73.8. Conversely, Planet Green Holdings (AMEX:PLAG) fell 6.5% to $1.74, with Chanson International (NASDAQ:CHSN) down 5.76% to $0.03. Overall, the session reflected mixed performance among consumer staples stocks.

benzinga_article

Waldencast

Sprouts Farmers

Medifast

VG Consumer Stap

SPDR FD Consumer Staples

iShares US Consumer Staples ETF

First Trust NASDAQ Food & Beverage

Target

Costco Wholesale

Kroger

Maison Solutions

Borealis Foods

Planet Green

Chanson

Moolec Science SA

IP Strategy

Top Wealth

AXIL Brands

WALDENCAST PLC C/WTS 27/07/2027 (TO PUR ORD)

BOREALIS FOODS INC C/WTS 07/02/2029 (TO PUR COM)

MOOLEC SCIENCE SA C/WTS 30/01/2028(TO PUR COM)

12 Consumer Staples Stocks Moving In Wednesday's After-Market Session

ZeroStack Corp. has secured $107 million in funding linked to its 0G token, acquiring nearly 21% of the total supply. The funding will involve the establishment of Texas Blocker, a subsidiary of ZeroStack, which will facilitate the transaction. Investors will contribute approximately 142 million native 0G tokens. The share exchange is anticipated to close around July 5, 2026, pending customary conditions and shareholder approval.

CoinLive

ZeroStack secures $107 million in 0G token funding, locking up nearly 21% of the 0G supply.

HODL

ARKB

ZeroStack Corp. announced a $107 million cryptocurrency financing to enhance its digital asset holdings and eliminate convertible debt. The financing involves a share exchange with Texas Blocker Corp., allowing ZeroStack to acquire 21% of the 0G Token ecosystem. The company plans to redomicile from Ontario to Texas, pending shareholder approval. CEO Daniel Reis-Faria emphasized the strategic importance of this move for the company's AI-focused asset management strategy, aiming to capitalize on the convergence of blockchain and AI.

- Zerostack Corp. has announced a definitive agreement for a $107 million private cryptocurrency financing to enhance its digital asset portfolio and balance sheet, aiming for long-term growth in decentralized AI.  
- Investors will exchange 142 million native tokens of the 0G blockchain for shares in Texas Blocker, a subsidiary of Zerostack, with plans for Zerostack to hold approximately 21% of the total 0G token supply.  
- The transaction is expected to strengthen the company's position in the AI and blockchain sectors, eliminate existing convertible debt, and facilitate a move from Ontario to Texas, though shareholder approvals are necessary.

StockTitan

VanEck Bitcoin ETF

ARK 21Shares Bitcoin ETF

Franklin Bitcoin ETF

Fidelity Wise Origin Bitcoin Fund - ETF

iShares Bitcoin Trust ETF

Core Scientific, Inc.

CoinShares Bitcoin ETF

American Bitcoin

ProShares Bitcoin Strategy ETF

WisdomTree Bitcoin Fund

Invesco Galaxy Bitcoin ETF

Bitwise Bitcoin ETF

Hut 8 Mining

Riot Platforms

Coinbase

Mara

ZeroStack Announces $107 Million Cryptocurrency Financing, Elimination of Convertible Note and Plan to Redomicile to Texas | ZSTK Stock News

516930

ARKG

Genflow Biosciences PLC has received administrative approval for €4 million in funding from the Wallonia Region to support the development of its gene therapy candidate GF-1002 for treating Metabolic Dysfunction-Associated Steatohepatitis (MASH). The funding is expected to be disbursed by May 2026 and aligns with the company's 2026 development priorities, focusing on capital efficiency and early-stage collaborations. CEO Dr. Eric Leire emphasized the importance of this funding in advancing their pipeline and maintaining a data-driven approach.

VG Health

Minsheng Royal CSI Biotechnology Theme ETF

Invesco Pharmaceuticals ETF

SPDR Pharmac

iShares Global Healthcare

Guotai CSI Bio-medicine ETF

GF CSI All Share Health Care ETF

Ark Genomic Revolution ETF

ChinaAMC SSE STAR Biology and Medicine ETF

VanEck Pharmaceutical ETF

Health Care Select Sector SPDR

E Fund CSI 300 Health Care ETF

iShares US Pharma

Genflow Biosciences PLC Announces Administrative Approval of Grant & 2026 Priorities | GENFF Stock News

FLGC

Flora Growth Corp. (NASDAQ: FLGC) has announced the withdrawal of its proposed public offering of common shares. This decision does not constitute an offer to sell or solicit any securities in jurisdictions where it would be unlawful. The company, which will be rebranded as ZeroStack, focuses on decentralized AI asset management and operates a global pharmaceutical distribution business through its subsidiary, Phatebo GmbH. The announcement includes forward-looking statements that involve risks and uncertainties, and the company disclaims any obligation to update these statements.

Flora Growth

Flora Growth Corp. Announces Withdrawal of Proposed Public Offering | FLGC Stock News

FLORA raised $42 million for its creative platform that pulls together top AI tools. Read its pitch deck.

businessinsider

FLORA raised $42 million for its creative platform that pulls together top AI tools. Read its pitch deck.

ZeroStack(ZSTK.US)

ZeroStack Corp. 1Q 2026: Revenue $7.27M, EPS $(3.68) — 10-Q Summary

ZeroStack | 10-Q: FY2026 Q1 Revenue: USD 7.274 M

12 Consumer Staples Stocks Moving In Wednesday's After-Market Session

ZeroStack secures $107 million in 0G token funding, locking up nearly 21% of the 0G supply.

ZeroStack Announces $107 Million Cryptocurrency Financing, Elimination of Convertible Note and Plan to Redomicile to Texas | ZSTK Stock News

Genflow Biosciences PLC Announces Administrative Approval of Grant & 2026 Priorities | GENFF Stock News

Flora Growth Corp. Announces Withdrawal of Proposed Public Offering | FLGC Stock News

FLORA raised $42 million for its creative platform that pulls together top AI tools. Read its pitch deck.